Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Antimicrob Agents Chemother ; 68(1): e0090323, 2024 Jan 10.
Artículo en Inglés | MEDLINE | ID: mdl-38095427

RESUMEN

Vancomycin taper and pulse regimens are commonly used to treat recurrent Clostridioides difficile infections, but the mechanism by which these regimens might reduce recurrences is unclear. Here, we used a mouse model to test the hypothesis that pulse dosing of vancomycin after a 10-day treatment course enhances clearance of C. difficile from the intestinal tract. Mice with C. difficile colonization received 10 days of once-daily oral vancomycin followed by 20 days of treatment with saline (controls), daily vancomycin, or pulse dosing of vancomycin every 2 or 3 days. Stool samples were collected to measure the concentration of C. difficile during and after treatment, vancomycin concentrations, and growth of vegetative C. difficile during every 3 days dosing. Pulse dosing of vancomycin was not effective in maintaining suppression of C. difficile (P > 0.05 in comparison to saline controls); growth of vegetative C. difficile occurred between pulse doses when vancomycin decreased to undetectable levels. Daily dosing of vancomycin suppressed C. difficile during treatment, but recurrent colonization occurred after treatment in more than 75% of mice, and by post-treatment day 14, there was no significant difference among the control, pulse dosing, and daily dosing groups (P > 0.05). These findings demonstrate that pulse dosing of vancomycin every 2 or 3 days does not facilitate the clearance of C. difficile spores in mice. Studies are needed to examine the impact of vancomycin taper and pulsed regimens in patients.


Asunto(s)
Clostridioides difficile , Infecciones por Clostridium , Humanos , Animales , Ratones , Vancomicina/farmacología , Antibacterianos/farmacología , Infecciones por Clostridium/tratamiento farmacológico , Modelos Animales de Enfermedad
2.
Infect Control Hosp Epidemiol ; 44(6): 1025-1028, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-35659791

RESUMEN

In a randomized trial, adjunctive ultraviolet-C light treatment with a room decontamination device and sodium hypochlorite delivered via an electrostatic sprayer were similarly effective in significantly reducing residual healthcare-associated pathogen contamination on floors and high-touch surfaces after manual cleaning and disinfection. Less time until the room was ready to be occupied by another patient was required for electrostatic spraying.


Asunto(s)
Infección Hospitalaria , Hipoclorito de Sodio , Humanos , Descontaminación , Electricidad Estática , Hospitales , Desinfección , Rayos Ultravioleta , Habitaciones de Pacientes , Infección Hospitalaria/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA